We are live on ! Find out more
EHWM

Eads & Heald Wealth Management Portfolio holdings

AUM $204M
1-Year Est. Return 28.27%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+28.27%
3 Year Est. Return
+84.36%
5 Year Est. Return
+119.71%
10 Year Est. Return
+418.36%
AUM
$197M
AUM Growth
+$20.3M
Cap. Flow
-$363K
Cap. Flow %
-0.18%
Top 10 Hldgs %
15.03%
Holding
148
New
5
Increased
49
Reduced
78
Closed
3

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$623K
2
CCK icon
Crown Holdings
CCK
+$380K
3
BMY icon
Bristol-Myers Squibb
BMY
+$242K
4
PRU icon
Prudential Financial
PRU
+$225K
5
BP icon
BP
BP
+$223K

Top Sells

Rank Stock Value
1
VRSK icon
Verisk Analytics
VRSK
+$329K
2
CBRE icon
CBRE Group
CBRE
+$300K
3
CRM icon
Salesforce
CRM
+$239K
4
LRCX icon
Lam Research
LRCX
+$238K
5
GPC icon
Genuine Parts
GPC
+$199K

Sector Composition

Rank Sector Weight
1 Healthcare 18.97%
2 Technology 15.68%
3 Industrials 15.57%
4 Consumer Staples 14.39%
5 Consumer Discretionary 12.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDT icon
101
Medtronic
MDT
$110B
$623K 0.32%
8,013
-1,770
-18% -$143K
AMD icon
102
Advanced Micro Devices
AMD
$798B
$622K 0.32%
9,601
-1,139
-11% -$75.2K
CRL icon
103
Charles River Laboratories
CRL
$12.8B
$621K 0.32%
+2,851
New +$623K
AMCR icon
104
Amcor
AMCR
$21.8B
$619K 0.31%
10,393
-81
-0.8% -$4.72K
PYPL icon
105
PayPal
PYPL
$51.1B
$595K 0.3%
8,356
-1,583
-16% -$127K
TFC icon
106
Truist Financial
TFC
$64.2B
$587K 0.3%
13,640
+1,062
+8% +$46.6K
FCX icon
107
Freeport-McMoran
FCX
$95.5B
$563K 0.29%
14,809
-1,400
-9% -$48.9K
IBM icon
108
IBM
IBM
$220B
$559K 0.28%
3,966
– –
ADSK icon
109
Autodesk
ADSK
$51.2B
$532K 0.27%
2,848
-263
-8% -$52.8K
MRSH
110
Marsh
MRSH
$92.2B
$526K 0.27%
3,180
– –
MRK icon
111
Merck
MRK
$317B
$497K 0.25%
4,482
+405
+10% +$41.4K
META icon
112
Meta Platforms (Facebook)
META
$1.5T
$475K 0.24%
3,943
-1,538
-28% -$181K
CBRE icon
113
CBRE Group
CBRE
$42.7B
$474K 0.24%
6,155
-4,061
-40% -$300K
INTC icon
114
Intel
INTC
$503B
$464K 0.24%
17,570
-286
-2% -$7.94K
CAT icon
115
Caterpillar
CAT
$395B
$432K 0.22%
1,803
-56
-3% -$12.2K
T icon
116
AT&T
T
$162B
$431K 0.22%
23,432
+9,424
+67% +$169K
CI icon
117
Cigna
CI
$72.7B
$428K 0.22%
1,292
+38
+3% +$12K
MKC icon
118
McCormick & Company Non-Voting
MKC
$14.1B
$426K 0.22%
5,140
– –
PCAR icon
119
PACCAR
PCAR
$69.5B
$397K 0.2%
6,017
-52
-0.9% -$3.4K
PFE icon
120
Pfizer
PFE
$149B
$383K 0.19%
7,482
-140
-2% -$6.71K
MS icon
121
Morgan Stanley
MS
$336B
$367K 0.19%
4,313
+120
+3% +$10.2K
ITT icon
122
ITT
ITT
$19.2B
$349K 0.18%
4,301
– –
CRM icon
123
Salesforce
CRM
$153B
$348K 0.18%
2,626
-1,637
-38% -$239K
C icon
124
Citigroup
C
$224B
$316K 0.16%
6,983
+605
+9% +$27.5K
MA icon
125
Mastercard
MA
$505B
$316K 0.16%
910
-3
-0.3% -$987
2 3 4
5
6

Similar funds

CAM
Concorde Asset Management Ann Arbor, Michigan $204M AUM
KFA
Kapstone Financial Advisors Lebanon, Ohio $204M AUM 22.12% 1-Year Est. Return
II
Ironclad Investments Maitland, Florida $204M AUM 16.26% 1-Year Est. Return
AA
Aufman Associates Sewickley, Pennsylvania $204M AUM 39.64% 1-Year Est. Return
WA1
Wimmer Associates 1 Pasadena, California $205M AUM 21.23% 1-Year Est. Return
OF
Optimize Financial Laguna Hills, California $203M AUM 57.91% 1-Year Est. Return
TCM
TAM Capital Management Stamford, Connecticut $205M AUM 28.94% 1-Year Est. Return
PKC
Palmer Knight Company Jacksonville, Florida $205M AUM 9.86% 1-Year Est. Return

Eads & Heald Wealth Management's Q4 2022 Portfolio in Review

As of Q4 2022, Eads & Heald Wealth Management held 148 positions worth $197M, up 12% from $176M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Eads & Heald Wealth Management's Q4 2022 filing shows 5 new, 49 increased, 78 reduced and 3 closed positions. Its largest new stake was Charles River Laboratories: 2,851 shares worth $621K. The largest sale was Verisk Analytics, an estimated $329K.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Industrials.

  • Eads & Heald Wealth Management's largest Q4 2022 buy was Charles River Laboratories: 2,851 shares worth $621K.
  • Eads & Heald Wealth Management added most to Crown Holdings in Q4 2022, an estimated $380K increase.
  • Eads & Heald Wealth Management's biggest Q4 2022 reduction was Verisk Analytics, cutting an estimated $329K.
  • Eads & Heald Wealth Management fully exited Cleveland-Cliffs in Q4 2022, selling an estimated $199K.
  • Eads & Heald Wealth Management's ten largest holdings make up 15% of its $197M portfolio in Q4 2022.
  • Eads & Heald Wealth Management opened 5 new positions and closed 3 in Q4 2022.
  • Eads & Heald Wealth Management's portfolio value rose 12% quarter-over-quarter to $197M.

Based on Eads & Heald Wealth Management's 13F filing for Q4 2022, filed 27 Jan 2023.